SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating buzz as a community-driven project aiming to replicate the massive growth of previous viral memecoins through active social media raiding and a transparent developer-led approach. While the community is currently focused on overcoming technical hurdles like securing official charts and listings, members are heavily incentivized by the potential for 1000x gains and a movement-based ethos that rejects typical 'pump and dump' behavior.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is attracting significant community attention as traders debate its potential for a breakout, with many highlighting the upcoming Layla upgrade in May 2026 as a pivotal catalyst for increased utility and quantum resistance. While bulls point to resilient price action and the network's low-fee, peer-to-peer focus, ongoing discussions remain polarized between those expecting a major decoupling from Bitcoin and critics dismissing the asset due to historical performance concerns.

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Nucor is trending as investors react to the anticipated formalization of 25% tariffs on global steel and aluminum imports. The community is actively discussing how these protective measures may bolster domestic manufacturing demand and pricing power, with some participants expressing caution regarding potential inflationary impacts and global trade volatility.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to heightened investor focus on the upcoming PDUFA decision date for RP1, with market participants debating whether the resubmission successfully addresses previous FDA concerns or if a second Complete Response Letter is likely. The community remains deeply divided, with some traders citing unusual options volume and potential short-covering as bullish indicators, while skeptics warn of significant downside risk if the company fails to secure accelerated approval.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is capturing significant investor attention as markets weigh the company's ambitious 2026 profitability guidance against its recent quarterly earnings miss. While the community remains deeply divided between those betting on long-term growth through AI-driven operational efficiency and skeptics concerned about medical loss ratios, retail traders are closely tracking the stock's volatility ahead of potential structural pivots in the healthcare sector.

SiriusXM Holdings, Inc. engages in the provision of audio entertainment. It operates through the Sirius XM and Pandora and Off-Platform segments. The Sirius XM segment features a wide range of content, including, music, sports, entertainment, comedy, talk and news channels, podcasts and infotainment services, all available in the United States on a subscription fee basis. The Pandora and Off-Platform segment generates a majority of its revenues from third parties advertising on the Pandora ad-supported service and other platforms. The company was founded on May 17, 1990, and is headquartered in New York, NY.

Sirius XM Holdings Inc.

Sirius XM Holdings Inc

Sirius XM Holdings is attracting intense investor attention as Berkshire Hathaway continues to aggressively increase its stake, signaling strong institutional confidence despite recent downward price pressure. The community is actively debating the company's valuation, dividend stability, and the potential impact of high short interest amid ongoing speculation regarding future content strategies and M&A activity.

Invesco DB US Dollar Index Bullish Fund - Common units of beneficial interest

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund is trending as market participants weigh conflicting signals between safe-haven demand amid rising Middle East geopolitical tensions and concerns over long-term fiscal deficits. Traders are actively debating the dollar's strength relative to precious metals and foreign currencies as they monitor key labor data and shifting central bank interest rate policies.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing increased investor attention as the company leverages a robust pipeline, including recent label expansions and the continued development of its oncology portfolio, to navigate patent cliffs. Market sentiment is bolstered by steady dividends and strategic collaborations, though traders remain focused on upcoming trial data readouts that will be critical for long-term growth and potential M&A activity.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending due to surging after-hours volume and unconfirmed speculation regarding a potential buyout, which has intensified community discussion about its valuation and long-term pipeline potential. Investors are closely monitoring unusual block trades and technical price action, viewing these signals as potential precursors to an M&A event despite historical skepticism regarding the company's independence.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is currently generating intense debate among retail traders, with many participants expressing extreme bearish sentiment and anticipation of further downward price movement. The community remains deeply divided, with vocal skeptics labeling the project a "ghost chain" while contrarian traders continue to monitor support levels in search of potential re-entry points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>TechCrunch reported, citing Indagari data, that Claude’s popularity has increased significantly over the last six months.</li><li>Reports said that Anthropic, OpenAI, and others are working on AI models that would be proficient in hacking.</li><li>Meanwhile, funds like KraneShares AI ETF, ARK Venture Fund (3.8%) and Fundrise Innovation Fund are gaining traction from retail investors for their stakes in top unlisted tech giants.</li></ul>With Anthropic eyeing an initial public offering as early as October, investors are increasingly looking for exposure to the fast-growing AI startup while closely tracking developments that could shape sentiment ahead of the listing.New data, first&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://techcrunch.com/2026/03/28/anthropics-claude-popularity-with-paying-consumers-is-skyrocketing/">reported</a> by TechCrunch, indicates that the Anthropic AI bot Claude gained paid subscribers at record levels.&nbsp;Consumer spending tracker Indagari analyzed anonymized credit card transactions from 28 million U.S. consumers and estimated that paid users for Clause, excluding enterprise users, more than doubled to nearly 600,000 from 250,000 through February.&nbsp;The TechCrunch attributed the bot’s surge in popularity to the ongoing clash between the U.S. government and Anthropic over defense-related AI use, as well as the company’s recent Super Bowl ads that&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://techcrunch.com/2026/02/13/anthropics-super-bowl-ads-mocking-ai-with-ads-helped-push-claudes-app-into-the-top-10/">took aim</a> at rival OpenAI’s ChatGPT.In separate but crucial news for the AI sector, Axios&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.axios.com/2026/03/29/claude-mythos-anthropic-cyberattack-ai-agents">reported</a>, citing AI and government officials, that Anthropic, OpenAI and other tech giants will soon release new models that could hack sophisticated systems at scale.&nbsp;In fact, last week, Fortune&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://fortune.com/2026/03/26/anthropic-says-testing-mythos-powerful-new-ai-model-after-data-leak-reveals-its-existence-step-change-in-capabilities/?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=sendto_newslettertest_csuite&amp;stream=top#_ga=2.267172493.2012405429.1774863814-1431982654.1771288787">reported</a> on an unpublished Anthropic blog post describing Mythos. The post said the model is "currently far ahead of any other AI model in cyber capabilities."As the potential IPO draws closer, investors are increasingly eyeing proxy funds that offer exposure to Anthropic. Stocktwits published an&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/anthropic-s-ipo-said-to-be-coming-as-early-as-october-here-s-how-to-pick-up-a-stake-before-it-goes-public/cZ3uU4aRIlA">explainer</a> on them last week.Only two ETFs –&nbsp;<a href="https://stocktwits.com/symbol/AGIX">KraneShares Artificial Intelligence &amp; Technology ETF (AGIX)</a> and&nbsp;<a href="https://stocktwits.com/symbol/DXYZ">Destiny Tech 100 (DXYZ)</a> – currently offer direct exposure to Anthropic, though allocations are relatively small and not fully disclosed.Retail-access private funds provide more meaningful exposure, with&nbsp;<a href="https://stocktwits.com/symbol/ARKVX">ARK Venture Fund (ARKVX)</a> (3.8%) and&nbsp;<a href="https://stocktwits.com/symbol/VCX">Fundrise Innovation Fund (VCX)</a> (20%) holding notable stakes in Anthropic.On Stocktwits, the retail sentiment was ‘bullish’ for AGIX and ‘extremely bullish’ for DXYZ, VCX and ARKVX. The sentiment for&nbsp;<a href="https://stocktwits.com/symbol/ANTHROPIC">Anthropic</a> was ‘neutral.’&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rzlv-jumps-13-ahead-of-half-year-report-analysts-expect-huge-upside-potential-this-year/cZERl20RIZF">RZLV Jumps 13% Ahead Of Half Year Report – Analysts Expect Huge Upside Potential This Year</a>&nbsp;

The Claude by Anthropic app logo appears on the screen of a smartphone

Anthropic’s Paid Users Reportedly Doubled Ahead Of IPO – Retail Piles Into Proxy Funds

Retail investors are increasingly eyeing exchange-traded and private funds that offer exposure to Anthropic ahead of its potential IPO in the fourth quarter.

Equity

Retail investors are increasingly eyeing exchange-traded and private funds that offer exposure to Anthropic ahead of its potential IPO in the fourth quarter.


<ul class="summary-bullets"><li>Started in 2021,&nbsp;Anthropic was last valued at $380 billion.</li><li>Reports say the AI firm is targeting a $60 billion raise, with the offering expected in October.</li><li>ETFs such as KraneShares Artificial Intelligence &amp; Technology ETF (AGIX) and Destiny Tech100 (DXYZ) hold Anthropic equity.</li></ul>AI upstart Anthropic is moving decisively toward a public listing, with a new report suggesting it has already held talks with investment banks and could launch its IPO as early as October. The offering is shaping up to be part of a mega wave of listings this year that is also expected to include OpenAI and SpaceX.Even before prospectuses are filed, some investors are getting ahead of the curve by gaining exposure through exchange-traded funds and private investment vehicles, products that have attracted significant interest over the past year.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-03-27/claude-ai-maker-anthropic-said-to-weigh-ipo-as-soon-as-october">reported</a>, citing sources, that Goldman Sachs, JPMorgan, and Morgan Stanley might be hired managers for Anthropic's IPO, which could raise a staggering $60 billion.Anthropic, founded by former OpenAI employees in 2021, is believed to be <a href="https://stocktwits.com/news-articles/markets/equity/why-anthropic-s-ipo-might-just-be-juicier-than-open-ai-s/cLIXYLXRE1c">quickly closing the gap</a> with OpenAI. According to reported internal projections, Anthropic expects to be profitable in 2028, while OpenAI expects $74 billion in operating losses that year.Anthropic has also left a mark more recently with the launch of a series of agentic AI tools as part of its offering, Claude Cowork, which triggered <a href="https://stocktwits.com/news-articles/markets/equity/saas-stocks-stumble-as-ai-fears-trigger-selloff-retail-eyes-selective-bets/cmUu4hVR49H">a widespread sell-off</a> in the shares of major software companies.Although the IPO timeline could vary, picking up exposure to Anthropic before the event is possible through the following funds:<figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Fund</td><td>Anthropic Exposure</td><td>Top 5 Holdings</td></tr><tr><td>KraneShares Artificial Intelligence &amp; Technology ETF (AGIX)</td><td>2.5%</td><td>Nvidia (5.1%), Microsoft (4%), Meta (3.9%), Alphabet (3.5%), Apple (3.3%)</td></tr><tr><td>Fundrise Innovation Fund (VCX)</td><td>20%</td><td>Databricks (17.7%), OpenAI (9.9%), Anduril (6.9%), Ramp (5.1%), Tesla (5%)</td></tr><tr><td>ARK Venture Fund (ARKVX)</td><td>3.8%</td><td>SpaceX (17.9%), Replit (4.9%), Figure AI (3.7%), Databricks (3.1%), Zipline (3%)</td></tr><tr><td>Destiny Tech100 (DXYZ)</td><td>Undisclosed</td><td>SpaceX (16.2%), Shield AI (4.1%), Databricks (4%), Beast Industries (3.5%), OpenEvidence (3.5%)</td></tr></tbody></table></figure>Source: Funds’ disclosures.<h2 class="st-heading-2"> Soaring Interest In Private Tech ETFs, Funds</h2>For now, only two exchange-traded funds – the KraneShares Artificial Intelligence &amp; Technology ETF (AGIX) and Destiny Tech100 (DXYZ) – offer direct exposure to Anthropic.About 2.5% of AGIX's holdings is currently Anthropic equity, while DXYZ’s Anthropic holding is much smaller and&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://destiny.xyz/tech100">not detailed</a> by the fund.&nbsp;ARK Venture Fund (ARKVX), a private fund that allows retail access, is another major source. About 3.8% of ARKVX’s portfolio is composed of Anthropic equity, in addition to large stakes in SpaceX, OpenAI, and several listed tech companies.Meanwhile, the Fundrise Innovation Fund (VCX), another private fund with retail access, held roughly 20% exposure to Anthropic.The funds are in high demand. Shares of the VCX have surged nearly 2,000% since listing last week, a key signal to investors in pre-IPO tech companies. ARKVX has returned 63% over the past year, sharply higher than the benchmark indices; DXYZ shares have declined 26% over the past 12 months.The funds are already a hit with retail investors. Watchers on Stocktwits for VCX have increased 2,000% in a week, while those for DXYZ and ARKVX have increased 32% and 22%, respectively, over the past month.Besides the funds, Amazon and Alphabet are among the largest investors with multi-billion-dollar stakes in Anthropic.<h2 class="st-heading-2">Anthropic Valuation Soars To $380B</h2>Anthropic was valued at about $380 billion following a $30 billion funding round led by MGX that closed in February. The company counts Alphabet, Google, Amazon, Microsoft, and Nvidia among its partners, each of which has also taken an equity stake and supplied specialized chips and other technology under agreements worth tens of billions of dollars.It’s been in the news recently over its fallout with the Pentagon over the use of AI in the defense business.&nbsp;The U.S. government designated the AI firm a supply chain risk – meaning it can’t do business with the government or any of its contractors – after Anthropic refused to remove safety guardrails that prevent its Claude AI from being used for fully autonomous weapons or mass domestic surveillance.On Thursday, Anthropic won a preliminary injunction, pausing the government’s plan to sever all ties with the company while the case is heard in the San Francisco federal court.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-s-tough-year-gets-slightly-worse-indie-game-devs-call-for-boycott-urge-peers-to-tank-stock-here-s-why/cZ3utfIRIlN">Nvidia's Tough Year Gets Slightly Worse: Indie Game Devs Call For Boycott, Urge Peers To 'Tank' Stock — Here's Why</a>&nbsp;

This photograph shows a smartphone screen displaying the logo of Anthropic, an American company specializing in artificial intelligence (AI). (Photo by Samuel Boivin/NurPhoto via Getty Images)

Anthropic's IPO Said To Be Coming As Early As October — Here's How To Pick Up A Stake Before It Goes Public

Anthropic is billed as one of the biggest forthcoming IPOs this year.

From SpaceX to xAI: How ETFs Are Packaging Private Assets

ETFs are opening doors to private markets: here's what investors need to know

KraneShares Trust - KraneShares Artificial Intelligence & Technology ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

AGIX
KraneShares Trust - KraneShares Artificial Intelligence & Technology ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AGIX News

AGIXKraneShares Trust - KraneShares Artificial Intelligence & Technology ETF